Authorization consideration is based on documentation that the requested study is for one or more listed clinical indications and, where relevant, supported by prior testing and risk factors.
Requested study selected: Provider checks the specific imaging study requested (MPI, Stress Echo, MUGA, Cardiac MRI, Coronary CTA, Preoperative/Postoperative evaluation, Evaluation during or prior to chemotherapy, Patient has physical limitation to exercise, TTE, TEE, Fetal Echo)>=1 study checked
See SECTION 4 and SECTION 5 study selection checkboxes
Clinical indication(s): One or more clinical reasons relevant to the requested study must be checked (examples: chest pain/suspected angina with specified features, associated conditions such as abnormal EKG, atrial fibrillation, cardiomyopathy, known CAD, new heart failure; other indications such as abnormal test results, anomalous coronaries, congenital heart disease, evaluation for myocardial viability, suspected constrictive pericarditis, quantification of intracardiac shunt or valvular regurgitation; TTE/TEE/fetal echo specific reasons as listed)>=1 indication checked
See SECTION 5 reason-for-study and indication lists
Chest pain features (when chest pain indication selected): Document checked characteristics: without other symptoms; exacerbated by exercise or relieved by rest; relieved with nitroglycerin; dyspnea; jaw pain; left arm/radiating pain; retrosternal locationdocument checked chest pain features when applicable
See chunk 5 chest pain checklist
Associated conditions and other indications: Document associated conditions checked (eg abnormal EKG, atrial fibrillation, cardiomyopathy, known CAD, new onset heart failure, prior transplant/aortic aneurysm/carotid stenosis) and other indications checked (eg abnormal test results with details, anomalous coronary artery, congenital heart disease, myocardial viability, pediatric acquired heart disease, suspected constrictive pericarditis, shunt or valvular regurgitation)document relevant associated conditions/other indications
See chunk 5 for full lists
Risk factors and symptoms: Document presence of CAD risk factors (age >40, family history of premature CAD, current smoker, diabetes, elevated cholesterol, hypertension, other) and symptoms with suspected cardiac etiology (chest pain, dyspnea, palpitations, syncope, ADL limitations) as applicabledocument relevant risk factors and symptoms
See chunks 5, 6, and 8 for risk-factor and symptom checklists
Prior testing documentation: Provide dates and results of prior cardiac testing when applicable (exercise stress test; MPI/PET/SPECT; stress echocardiogram; cardiac MRI; cardiac catheterization; coronary CTA; EKG; MUGA; TTE/TEE; other)provide dates/results when prior tests exist
See chunk 6 previous tests grid
TTE / TEE / Fetal Echo specific reasons: For TTE: document reasons such as abnormal test results, acquired pediatric heart disease, aortic disease, arrhythmias, congenital heart disease, device evaluation. For TEE: document reasons such as evaluation for cardiomyopathy, known or suspected fetal cardiac disorder, murmur or click, pericardial disease, pulmonary hypertension, pre-op/post-op, and symptoms assessing structural heart disease. For Fetal Echo: document reasons such as suspected cardiac mass, suspected or known endocarditis, valvular disease, ventricular function, suspected cardiac source of embolus, peripheral embolic event, TIA/stroke, and other relevant findings.document applicable echo-specific indications
See chunks 7, 8, and 9 for modality-specific indication lists
Supporting documentation and completeness: Attach any additional data relevant to medical necessity (detailed prior test results, dates, and clinical notes). Failure to provide completed clinical indication selections, prior test dates/results, requested CPT/ICD codes, and required administrative information may result in incomplete review or denial of the prior authorization request.attach supporting data and complete all required fields
See chunks 6 and 8–9 for prior tests and plan guidance